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Abstract
Objective: To determine the conformity of HPV type 16 
and 18 in cervical and oral/buccal specimens from cervical 
cancer patients.
Methods: A cross-sectional study was conducted in March 
- September 2016 at several hospitals in Makassar. HPV 16 
and 18 genotyping in cervical and oral fl uid of 77 patients 
with cervical cancer performed with PCR method.
Results: The prevalence of HPV type 18 infection both in 
the cervical and the oral fl uid was higher than HPV type 
16 [9(47.4%) vs 5(26.3%)]. The agreement of HPV type 18 
infection (r=0.328;p=0.000) in the cervical-oral sites was 
higher than HPV type 16 (r=0.194;p=0.042).
Conclusions: HPV type 16 and 18 could infect both cervix 
and oral cavity although type-specifi c concordance is low.
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Abstrak
Tujuan: Mengetahui tingkat kesesuaian hasil pemeriksaan 
HPV tipe 16 dan 18 antara spesimen serviks dan oral/buccal 
pada penderita kanker serviks
Metode: Penelitian potong lintang ini dilakukan pada Maret 
– September 2016 pada beberapa rumah sakit di Makassar. 
Pemeriksaan HPV 16 dan 18 pada cairan serviks dan oral 
dari 77 orang penderita kanker serviks menggunakan teknik 
PCR.
Hasil: Prevalensi infeksi bersama pada serviks dan oral 
HPV tipe 18 lebih tinggi dibandingkan HPV tipe 16 
[9(47,4%) vs 5(26,3%)]. Tingkat kesesuaian antara HPV tipe 
18 (r=0,328;p=0,000) pada serviks dan oral lebih tinggi 
dibandingkan tipe 16 (r=0,194;p=0,042).
Kesimpulan: HPV tipe 16 dan 18 dapat menginfeksi serviks 
dan oral meskipun tingkat kesesuaian kedua tipe ini lemah.
Kata kunci :human papillomavirus, kavum oral, serviks
INTRODUCTION 
Persistent infection of HPV high-risk types in the 
cervix uteri is a major cause of invasive cervical 
cancer and its precursor.1 In addition to cervical 
cancer, HPV is also known to cause 0.7% of other 
cancer types including anal, vaginal, vulvar, penile 
and oropharyngeal cancer in women and men.2,3
HPV16 and HPV18 are the cause of 50% and 
20% of cervical cancer cases globally.4 HPV type 
16 is also more common in oral carcinoma than 
other types (types 18, 31 and 33).5A study shows 
there is a strong correlation between high-risk 
HPV infection with oral squamous cell carcinoma.6-
8Another study on the oral mucosa of women 
with cervical lesions shows the progression of 
CIN associated with HPV16 infection in buccal.9 
The prevalence of oral HPV infection is fi ve times 
higher in women with cervical HPV infection 
compared with those without infection with HPV 
types although the agreement rate concordance 
rate between cervical and oral specimen was low.10 
Conformity of HPV types both in oral and cervical 
allow exploring the differences and relationships 
between them.
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METHODS
A cross-sectional study was conducted on cervical 
fl uid and oral/buccal fl uid from 90 cervical 
cancer patients from March to September 2016 
in Wahidin Sudirohusodo hospital and affi liated 
hospitals at Department of Obstetrics and 
Gynecology, Faculty of Medicine, Universitas 
Hasanuddin. Cervical cancer diagnosis and HPV 
genotyping with PCR technique performed 
at the Laboratory of Pathology, Department 
of Pathology Faculty of Medicine, Universitas 
Hasanuddin. Data were analysed using SPSS and 
differences were considered to be signifi cant if 
p<0.05.
RESULTS
We examined HPV types 16 and 18 at the buccal 
and cervical fl uid from 90 cervical cancer patients 
but only 77 patients enrolled in the study because 
13 samples from 13 patients had lysis. HPV types 
16 and 18 found in cervical fl uid and oral/buccal. 
This study showed 38 (49.4%) of cervical cancer 
patients aged 40-49 years, 61 (79.2%) multiparous 
and 35 (45.5%) using contraception (22.1% using 
contraceptive injections/DMPA) (table 1).
HPV low-risk and high-risk found in both 
cervical fl uid and oral/buccal. The prevalence 
of high-risk HPV more prevalent in the cervix 
compared to oral/buccal. The cervical fl uid 
contains only 1 (1.3%) low-risk HPV (type 53) 
whereas high-risk HPV were found type 16 
(34.2%), 18 (40.8%), 33 (3.9%), 45 ( 9.2%) and 51 
(10.5%). In the oral/buccal there are two low-risk 
types of HPV, which are type 11 (3.4%) and 42 
(10.3%) whereas high-risk HPV type consists of 
type 16 (31%), 18 (37.9%) and 45 (17.2%). This 
study also showed that the prevalence of cervical 
and oral together with HPV types 18 is higher 
than HPV 16 (47.4% vs 26.3%). The prevalence 
of HPV types 18 higher than in other high-risk 
types of HPV both cervical and oral/buccal (Table 
2). Level of concordance between HPV type 18 
r=0.328;p=0.000)  in cervical and oral higher than 
type 16 (r=0.194;p=0.042) (table 3).
Table 2. HPV Type in Cervical and Oral/Buccal Specimen
Cervical
n(%)
HPV
High-risk
16
18
33
45
51
Low-risk
11
42
53
26(34.2)
31(40.8)
3(3.9)
7(9.2)
8(10.5)
-
-
1(1.3)
9(31)
11(37.9)
-
5(17.2)
-
1(3.4)
3(10.3)
 -
5(26.3)
9(47.4)
-
5(26.3)
-
-
-
-
Oral
n(%)
Cervical and Oral 
n(%)
Table 3. Correlation of HPV Types 16 and 18 between Cervical and Oral
Cervical and oral of HPV type Kappa P-value
16
18
0.194
0.328
0.042
0.000
Table 1. Sample Characteristic
Characteristic n %
Age (years)
20-29
30-39
40-49
>50
Parity
Nulliparous
Multiparous
Contraception
No
Pil
Injection
Condom
Tubectomi
3
15
38
21
16
61
42
11
17
6
1
3.9
19.5
49.4
27.3
20.8
79.2
54.5
14.3
22.1
7.8
1.3
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DISCUSSION
In the present study, we found the prevalence 
of HPV type 18 in the cervix and oral was higher 
than that of type 16. Evidence from virologic, 
molecular, clinical and epidemiological studies 
has identifi ed HPV as a primary etiologic agent 
in cervical cancer.11,12 HPV types 16 and 18 are 
the cause of 70% of all invasive cervical cancers 
compared to HPV types 45, 31 and 33.1,13,14 
However, this results are different from Syrjanen 
who obtained HPV type 16 is the most common 
found in oral carcinomas compared to other types 
(18, 31 and 33).5 Epidemiological studies by Vet in 
Jakarta, Tasikmalaya, and Bali on screening 2686 
women obtained HPV type 16 with the highest 
prevalence (11.4%) through Pap smear and PCR 
techniques.15 High-risk HPV types, 16, 18, and 
45 were found both in cervical and buccal while 
two other types (33 and 51) were only found in 
the cervix with higher prevalence than buccal. 
The present study shows the similar prevalence 
of types 16 and 18. This prevalence difference 
may be due to population differences and study 
characteristics. We did not  assess whether oral 
HPV infection  causes oral carcinoma and the 
presence or absence of lesions in the oral cavity. 
Age is a major factor in cervical cancer due 
to HPV infection. The prevalence of women in 
their 20's is infected with high and low-risk HPV 
between 20%-40%.16 Our study also shows that 
the highest HPV type 16 infection occurs at age 
25-40 years compared to HPV type 18 for the 
same age group following the risk of infection 
decreases with age.17,18 The number of cervical 
cancer patients in this study increased from age 
20 to 40 years and then decreased after the age of 
>50 years. Cervical cancer risk factors also increase 
due to the use of hormonal contraceptives. Use 
of oral contraceptives (progestogen-only pill) and 
injections (DMPA) for more than 5 years increase 
the risk of cervical cancer.19
Women infected with genital HPV had a 
higher frequency of oral HPV infection, according 
to a study by Giraldo et al. Cytological and Pap 
smear examination showed the presence of HPV 
in the oropharynx epithelium of women infected 
with genital HPV.20 A study on the oral mucosa 
of women with cervical lesions indicates the 
progression of CIN is associated with HPV 16 
infection in buccal.9 High prevalence of oral HPV 
is reported in women with cervical and oral HPV 
infection.21-24 Oral infection with HPV type 16 is 
a strong risk factor for oropharyngeal cancer. 
The prevalence of oral HPV is lower than that of 
the cervix2 while another study shows the same 
prevalence.3The present study did not examine the 
sexual behaviour of the patients. Several factors 
affecting cervical HPV infection against oral HPV 
infection include differences in the prevalence of 
HPV based on anatomical sites (cervix and oral), 
and the distribution of HPV types was not fully 
understood.21
We also found high-risk HPV infection (16 and 
18) in oral lower than the cervix. The prevalence 
of genital HPV infection is much higher than 
that of oral HPV infection. This is may be due to 
the production of saliva that can dilute the HPV 
signal. Some studies suggested that saliva can be 
protective against HPV because of antimicrobial 
agents such as lysozyme, lactoferrin and 
immunoglobulin A against the viral infections.24
The prevalence of HPV in normal oral mucosa 
varies depending on the different types of 
samples, mode of retrieval, virus detection 
methods, sensitivity levels, PCR primers used 
and PCR inhibitor.7,11,21 Oral sampling technique 
requires special attention as important in 
accurately detecting the presence of HPV such 
oral sampling technique should be able to obtain 
high-quality DNA. Methods of collecting samples 
in the oral cavity and oropharynx to obtain viral 
DNA virus usually performed with brushing and 
mouth rinse method or rinse.22,25,26 Garcia-Clocas 
et al. study that compared the method of mouth 
rinse and brushing to obtain the DNA genome 
concluded one mouthwash sample obtain more 
DNA than the two brushing samples, but both 
methods were adequate in isolating the DNA 
required for PCR examination. Mouthwash is the 
preferred method for knowing the epidemiology 
of oral HPV DNA. However, the possibility 
of obtaining a large positive sample may be 
used in combination of several concurrent oral 
sampling methods.25 HPV detection methods in 
malignancy with PCR have better sensitivity and 
specifi city compared to the standard methods 
(Southern blot technique, in situ hybridisation, 
immunohistochemistry).27
The present study obtained low concordance 
rates infection of HPV types 16 and 18. Prevalence 
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of oral HPV infection in saliva samples by 24% in 
women with HPV cervical lesions.28 Another study 
has shown a low risk of high-risk HPV infection in 
the oral cavity of women with cervical cancer.29 
Although co-infection with low-risk HPV types, 
cervical and oral HPV infections is not independent 
so that cervical HPV infection may be a risk factor 
for oral HPV infection.10 The prevalence of oral HPV 
and cervical infection in 221 women infected with 
HPV was 16.7%.21Oral infection is more common 
in women with cervical HPV infection compared 
to women without cervical infection (25.5% vs 
7.9%). A study by Canadas found the prevalence 
of infection with cervical and oral HPV was lower 
than Fakhry et al. study (12.7% vs 5%).30 Further 
study has shown that the prevalence of oral HPV 
infection is 5-fold higher in women with cervical 
HPV infection than without infection (7.0% vs 
1.4%) and among 3% of women infected with 
oral HPV or cervical studies. The suitability rate of 
6.6% indicating there is a relationship between the 
two sites although the agreement rate was low.10
CONCLUSION
In conclusion, HPV types 16 and 18 can infect the 
cervix and oral although the agreement of these 
two types HPV is weak.
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